Floatz logo

Von Willebrand Factor

Type 3 Von Willebrand's Disease

Fondazione Angelo Bianchi Bonomiprotein_peptideDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Type 3 Von Willebrand's Disease cohort.

Asset / SponsorPhaseRating
Emicizumab
Bleeding and Clotting Disorders Institute Peoria, Illinois
Phase 1CC

Same molecule, other indications

Von Willebrand Factor is also rated in:

von Willebrand disease (hereditary or acquired)Dormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →